ArticleSignal transduction and targeted therapy2026
Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma.
Minghao Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it